Junior Research Group

Pediatric Immuno-Oncology

  • Immunology, Infection and Cancer
  • KiTZ
  • Junior Research Group

Dr. Dr. Franziska Blaeschke

Group Leader

Our junior research group investigates new immunotherapies for the treatment of childhood cancers.

Our Research

Our immune system is not only capable of fighting infections but can also, in principle, recognize and eliminate cancer cells. The principle of immunotherapy involves "training" the immune system to fight cancer. This is achieved, for example, through genetic modification of specific immune cells called T cells. These T cells can be engineered to carry a chimeric antigen receptor (CAR) on their surface. The resulting CAR T cells can then recognize and eliminate cancer cells in the patient’s body. This type of therapy has already been highly successful in treating children and adolescents with a specific type of blood cancer (lymphoblastic leukemia). Unfortunately, the therapy has so far been less effective for other forms of blood cancer (myeloid leukemia) and most solid tumors (e.g., brain tumors or bone tumors). We aim to change this! Our research projects focus on questions such as: What strategies have tumors developed to evade detection by the immune system? How can CAR T cells recruit other immune cells for help? How can we optimize T cells to effectively migrate to solid tumors and eliminate them?

The techniques performed in our laboratory include genetic engineering (e.g., using CRISPR/Cas9, lentiviruses, or retroviruses), cell culture, flow cytometry, CRISPR screens, next-generation sequencing, various tumor models, and functional analyses (e.g., characterizing CAR T cell function). Our projects are carried out in close collaboration with colleagues at the DKFZ, KiTZ, and UKHD, as well as with our national and international partners.

Together, we aim to unravel the functionality of immune cells in cancer and develop a new generation of immunotherapies for cancer treatment.

Team

We are an international team with expertise in genetic engineering, immunotherapy, tumor models, pediatrics, immunology, genomics, bioinformatics and CRISPR screens.

6 Employees

  • Dr. Dr. Franziska Blaeschke

    Group Leader

    Contact form: Message to Dr. Dr. Franziska Blaeschke

    Form data is loaded ...

  • Dr. Oren Barboy

    Postdoc

    Contact form: Message to Dr. Oren Barboy

    Form data is loaded ...

  • Kathleen Grüter

    PhD Student

    Contact form: Message to Kathleen Grüter

    Form data is loaded ...

  • Eva Koitschev

    Master's Student

    Contact form: Message to Eva Koitschev

    Form data is loaded ...

  • Monika Kuban

    Lab Manager

    Contact form: Message to Monika Kuban

    Form data is loaded ...

  • Konstantin Loher

    PhD Student

    Contact form: Message to Konstantin Loher

    Form data is loaded ...

Open Positions

If you're interested in working with us, please reach out to franziska.blaeschke(at)kitz-heidelberg.de. Clinician scientists are encouraged to apply through the DKFZ Clinician Scientist Program: https://www.dkfz.de/en/karriere/dkfz-clinician-scientist-program/how-to-become-a-clinician-scientist-at-dkfz/research-profiles
 

Selected Publications

2023 - Cell
2022 - Nature
2022 - Science
2021 - Blood Cancer Journal

Get in touch with us

Dr. Dr. Franziska Blaeschke
Group Leader
Contact form: Message to Dr. Dr. Franziska Blaeschke

Form data is loaded ...